Search Results
Results found for "Jan Voss"
- Our History | Dr. GPCR Ecosystem
Invited to the 9th GDR Meeting with Beyond the Lab . 2021 Expanding the Conversation Podcast Milestones Jan Unige with Leadership Is a Learned Skill . 2023 A Year of Reflection and Growth Podcast Milestones Jan
- Dr. Thomas P. Sakmar | Dr. GPCR Ecosystem
approaches for membrane proteins in collaborations with Thomas Huber , Xavier Periole , and Siewert-Jan
- Tore Bengtsson: Rethinking β₂-Adrenergic Signaling in Metabolic Disease | Dr. GPCR Ecosystem
Jan Nedergaard, pioneers in thermogenesis research. Have a Fundamental Limitation Traditional β₂-adrenergic agonists can stimulate muscle growth and fat loss
- Ross Cheloha: Nanobody-GPCR Conjugates and the Engineering of Receptor Selectivity | Dr. GPCR Ecosystem
. << Back to podcast list Strategic Partner(s) Ross Cheloha: Nanobody-GPCR Conjugates and the Engineering Ross Cheloha approaches these questions from a chemical biology perspective - using synthetic peptide About the Guest Ross Cheloha is a tenure-track investigator at the National Institute of Diabetes and Ross Cheloha is an Investigator at the National Institutes of Health in the Laboratory of Bioorganic Ross Cheloha on the web NIDDK Cheloha Lab Google Scholar LinkedIn Twitter ResearchGate Dr.
- Xylazine, Fentanyl, and the Fight for Breath with Catherine Demery | Dr. GPCR Ecosystem
gripping conversation, Catherine, a PhD candidate at the University of Michigan, shares how personal loss How loss and lived experience can sharpen scientific focus. But loss has a way of sharpening focus—friends lost to overdose brought the opioid epidemic into painful
- Terms and Conditions | Dr. GPCR Ecosystem
Ecosystem.DrGPCR.com shall not be responsible or liable, directly or indirectly, for any damage or loss the third party, and the Customer agrees that Ecosystem.DrGPCR.com shall not be held liable for any loss is not liable, and Customer agrees not to hold Ecosystem.DrGPCR.com responsible, for any damages or losses (including, but not limited to, loss of money, goodwill or reputation, profits, or other intangible attorneys, advertisers, product and service providers, and affiliates harmless from any liability, loss
- Masha Niv: Bitter Taste Receptors and the Drug Discovery Blind Spot | Dr. GPCR Ecosystem
science - how a global consortium formed from a handful of tweets and what it found about taste and smell loss COVID-19 taste loss was a scientific detour that became something larger Niv had not planned to work and found that while both smell and taste are impaired in the majority of symptomatic cases, smell loss unexpected result - heavy water activates the T1R2/T1R3 heterodimer 23:53 - COVID-19 and chemosensory loss
- Dr. Ralf Jockers | Dr. GPCR Ecosystem
He discovered multiple rare and loss-of-function variants of the MT2 melatonin receptors that are associated
- Beatriz Blanco-Redondo: Adhesion GPCR Discovery in Drosophila | Dr. GPCR Ecosystem
it tractable: new lines in weeks, knockouts in months, and behavioral readouts that connect receptor loss to human vascular and neurological pathology In the peripheral nervous system of Drosophila larvae, loss
- Silvio Gutkind: Building a Lab That Doesn't Shut Down | Dr. GPCR Ecosystem
Gutkind — carrying a personal loss in New York and leading a cancer center building that operated at
- Self-Learning, Collaboration, and Delegation in Science with Dr. Badr Sokrat | Dr. GPCR Ecosystem
She also mentioned the importance of careful communication, especially when working with a boss who has
- Silvio Gutkind: When GPCRs Drive Cancer | Dr. GPCR Ecosystem
In knockout mice, loss of CXCR3 abolishes response to both anti-PD-1 and anti-CTLA-4, reframing the receptor
- Paul Insel: Rethinking COVID-19 Pathobiology Through GPCR Signaling | Dr. GPCR Ecosystem
a disease of signaling imbalance: an overdrive of AT1R activation by angiotensin II, paired with a loss
- Terry Hebert: How Cellular Background and Localization Influence GPCR Function | Dr. GPCR Ecosystem
knockout cell is intrinsically different from the wild-type — complicating any conclusions drawn from loss-of-function
- Michel Bouvier: BRET, Biased Agonism, and the Tools That Changed GPCR Pharmacology | Dr. GPCR Ecosystem
This conversation covers the arc of that career: the personal loss that drew Bouvier toward the sympathetic
- Why Mosquitoes Hunt You: GPCR Control of Blood Feeding and Mating | Dr. GPCR Ecosystem
As a postdoctoral researcher in Leslie Vosshall’s laboratory at Rockefeller University, Dr.















